Previous research has prompted warnings from North American and European health agencies of severe exacerbations associated with gabapentinoid use by patients with COPD. The researchers compared data ...
Please provide your email address to receive an email when new articles are posted on . After using an antidepressant, the risk for pneumonia and COPD exacerbations went up. Discontinuing ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Hospitalization duration for a COPD exacerbation was ...
Background In real-world chronic obstructive pulmonary disease (COPD) care, poor adherence often leads to treatment ...
High-intensity noninvasive positive pressure ventilation (NPPV) might have reduced need for endotracheal intubation for persistent hypercapnia during acute exacerbation of chronic obstructive ...
Decreased body mass index (BMI) in patients with chronic obstructive pulmonary disease (COPD) was linked to a higher risk of severe exacerbations and all-cause mortality, emphasizing the importance of ...
Gabapentinoid use in patients with chronic obstructive pulmonary disease (COPD) was associated with a higher risk for severe exacerbations, a population-based cohort study from Canada indicated. Among ...
This article supports the use of the chronic obstructive pulmonary disease (COPD) treatment ratio as a surrogate marker of COPD exacerbation risk for quality measurement purposes. Objectives: Despite ...
The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...
Almost 16 million adults have COPD in the United States and about 3 in 4 people with this condition have at least one flare (exacerbation) a year, cites a review. But you don’t have to sit and wait ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback